LCMS webinars focusing on LC/MS/MS - page 108

In this webinar we will discuss about Clinical Mass Spectrometry: LC-MS/MS based confirmatory tests for Dried Blood Spot screening.

The purpose of this work is to demonstrate a direct injection determination of acrylamide and haloacetic acids in drinking water that exceeds the requirements for the new EU Drinking Water Directive 2020.

The chemical composition of e-liquids for electronic cigarettes has been evaluated since 2015, using TOF MS, HS-GC-FID, GC-MS, and LC-MS/MS.

This webinar highlights a workflow to characterize AAVs (Adeno-associated viruses) via LC/MS, including post-translational modification identification of the capsid proteins.

In this webinar we will demonstrate an automated LC/MS workflow to quantify intact mAb drugs in mouse plasma. The workflow uses an Agilent AssayMAP Bravo and an Agilent 6545XT AdvanceBio LC/Q-TOF system.

This webinar will be focused on the Toxtyper drugs-of-abuse (DOA) LC-MSn method and how it compares with the currently used immunoassays (CEDIA, EMIT and DRI) for urine toxicology routine panels.

Dr. Karl Abele will describe Solvias approach to N-Nitrosamine analysis focusing on Generic quantification of six volatile N-nitrosamines and Use of HRAM-LC/MS equipment.

We will clearly demonstrate how and why a single-stream sample preparation technique with both LC/MS/MS and GC/MS/MS platform analysis working in parallel offers a robust, high-throughput methodology.

Host cell protein analysis by SWATH LC-MS is overcoming several of ELISA method challenges and has multiple advantages for identification and quantification of HCP and manufacturing process related impurities.

In this presentation, we will describe how to use the recently released Thermo Scientific Proteome Discoverer 2.5 software for high confidence identification and quantification of complex proteomics datasets.